Media

2022 Q2

Podcast

Head of Research, Derren Nathan and Head of Corporate Broking, Niall Pearson join UK Investor Magazine on their latest Podcast

2022 Q1

Interview

Derren Nathan, Head of Research at Hybridan LLP sits down with Master Investor to discuss their latest research on 'The Evolution of Fintech'

Interview

Derren Nathan, Head of Research from Hybridan LLP talks to Proactive London about their latest research on 'The Evolution of Fintech'.

2021 Q4

Interview

Derren Nathan, Director and Head of Research at Hybridan LLP joins Master Investor's Sarah Lowther to discuss the rapidly developing technology and industries surrounding the evolution of the hydrogen economy.

Webinar

Hybridan's CEO, Claire Noyce, joins the Small Cap Network to discuss The Opportunities and Challenges of becoming a public Company

2021 Q3

Interview

Hybridan's Head of Corporate Broking, Niall Pearson, sits down with DirectorsTalk to provide a brief overview of Symphony Environmental, how they've adapted from Covid and some background around their pivotal deal with Meditech.

2021 Q2

Podcast

Hybridan CEO, Claire Louise Noyce, joins Beyond Governance's podcast to discuss DEI in UK capital markets.

Presentations

Hybridan Head of Research, Derren Nathan featured on the The Quoted Companies Alliance Catching the Analysts' Eye Programme. Derren shares his thoughts on what companies can do to stand out from the crowd:

Hybridan CEO, Claire Louise Noyce chairs a Master Investor sponsored
round table webinar, reviewing Small Caps in 2021.

2021 Q1

Articles

Derren Nathan of Hybridan takes a detailed look at Sareum Holdings who is investigating small molecule in the treatment of auto-immune disease, cancer, and with the award of a recent NIHR grant, severe phase Covid-19.

2020 Q4

Presentations

At this year's Master Investor Show, Hybridan CEO, Claire Noyce was asked to provide a market overview of 2020 and an outlook for markets in 2021

Articles

Hybridan's CEO, Claire Noyce shares Top 5 tips for launching a fast-growth business during a pandemic

Derren Nathan of Hybridan takes a detailed look at Rural Broadband Solutions, which specialises in providing fibre quality broadband to rural communities.

Goliath investors are all very well, but don’t forget David. Hybridan article in the autumn issue of the Investor Relations Society magazine Informed

2020 Q3

Articles

The tide is beginning to turn for plastic technologies firm Symphony Environmental, writes Derren Nathan of Hybridan in Master Investor's Stocks in Focus Column.

2020 Q2

Articles

An accredited NHS software creator is poised to enter a new growth phase with next-generation, digital, clinical-support engines, as healthcare systems worldwide feel the strain, writes Hybridan's Derren Nathan on Master Investor's Stocks in Focus Column

Presentations

Claire Louise Noyce talks with the lifescience community “Coffee Buddies” online in Zoom about the lifescience sector on the UK markets in Covid-19 times, companies to watch, sectors to look out for within lifesciences and general market sentiment.

Presentations

In advance of the announcement of the Shortlist for the 2020 Small Cap Awards, Chair of the Judging Panel, Claire Noyce discusses the judging process with Master Investor Editor-in-Chief, James Faulkner.

While market participants are looking for clarity on the Covid-19 situation, there is still plenty that company management teams can do in the meantime, argues John Beresford-Peirse of Hybridan.

2020 Q1: ARTICLE

Small caps are certainly poised for a return to the limelight, and more generally 2020 feels like it is going to be a better year all round, writes Claire Noyce.

2020 Q1: PODCAST LINK

The View from the Trenches: The year ahead
Welcome to the second episode of The View from the Trenches, the show where we give listeners the rundown on all the latest action right from the Heart of the City of London. In this episode, we discuss the market outlook for 2020 and the key themes that could dominate in the year ahead.

The View from the Trenches: Signs of life?
Welcome to the third episode of The View from the Trenches, the show where we give listeners the rundown on all the latest action right from the Heart of the City of London. In this episode, we discuss two new IPOs and some of the more interesting situations in the small cap space.

2019 Q4: PODCAST LINK

The View from the Trenches: This episode is the first in a new series entitled The View from the Trenches; an insight into the markets from the vantage point of institutional stockbroker and Director Niall Pearson, discussing all the latest market developments from the coal face in the City of London. The first episode looks at the slowdown in the IPO market and its implications for investors.

2018 Q4

O2 puts IPO on hold against backdrop of London flotation failures

2018 Q3

How small caps can tackle investor prejudice

2016 Q2

Crossword Cybersecurity at top of the game - Hybridan's Nathan

Cyber Security – Picking a Winner

2016 Q1

Hybridan analyst talks support sector stock picks

How to Invest in Mining: Proactive Investors presents a beginners guide

2015

Niall Pearson on the US pricing pressure on the Biotech Sector

William Lynne discusses opportunities for investors in the FinTech Sector

Niall Pearson provides his thought on the Biotech sector and explains the valuation gap.

Derren Nathan picks out some junior miners he believes offer good values and long-term potential to investors in current low commodity price movements.

William Lynne believes ‘transitional’ stocks offer more compelling values for small cap investors.

Niall Pearson talks about information needed to gauge on what could be a great investment in the resources sector and what to avoid.

Niall Pearson suggests small-cap mining companies are ‘not out of the woods yet’ with the sector still under plenty of pressure.

2014

Derren Nathan on what to look for in a biotech investment and that there is demand from investors for companies with revenues and diversified later-stage portfolios.

Niall Pearson discusses the record amounts raised on AIM in 2014 and why it has been ‘a funny year’.